<code id='67F6BE1690'></code><style id='67F6BE1690'></style>
    • <acronym id='67F6BE1690'></acronym>
      <center id='67F6BE1690'><center id='67F6BE1690'><tfoot id='67F6BE1690'></tfoot></center><abbr id='67F6BE1690'><dir id='67F6BE1690'><tfoot id='67F6BE1690'></tfoot><noframes id='67F6BE1690'>

    • <optgroup id='67F6BE1690'><strike id='67F6BE1690'><sup id='67F6BE1690'></sup></strike><code id='67F6BE1690'></code></optgroup>
        1. <b id='67F6BE1690'><label id='67F6BE1690'><select id='67F6BE1690'><dt id='67F6BE1690'><span id='67F6BE1690'></span></dt></select></label></b><u id='67F6BE1690'></u>
          <i id='67F6BE1690'><strike id='67F6BE1690'><tt id='67F6BE1690'><pre id='67F6BE1690'></pre></tt></strike></i>

          Wikipedia

          Wikipedia

          author:entertainment    Page View:34949
          Blockchain data -- health tech coverage from STAT
          Adobe

          This year has seen the Federal Trade Commission crack down on digital health companies’ irresponsible data use. Since February, it has charged four companies with improperly handling sensitive health information — starting with the first-ever enforcement of its long-stagnant Health Breach Notification Rule, against GoodRx.

          Now, the FTC is arming itself for even more aggressive enforcement. In June, it proposed changes to the Health Breach Notification Rule that would clarify its ability to regulate digital health companies and their use of health data — filling in some of the gaps left by the patient privacy law HIPAA, which in many cases doesn’t cover the fast-growing world of online and app-based health and wellness services.

          advertisement

          “The FTC is seeking to put developers of these kind of apps on notice that they, too, have responsibilities to protect health data,” said Angie Matney, counsel focused on data privacy at the law firm Reed Smith.

          Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

          GET STARTED Log In

          comprehensive

          Drug repurposing or repositioning? The language matters
          Drug repurposing or repositioning? The language matters

          AdobeFindinganewmedicineisnevereasy.Butdevelopingtreatmentsforpatientswithrarediseases—conditionstha

          read more
          'Null' research findings aren't empty of meaning. Let's publish them
          'Null' research findings aren't empty of meaning. Let's publish them

          APStockEverymedicalresearcherdreamsofdoingstudiesorconductingclinicaltrialsthatgenerateresultssocomp

          read more
          BioMarin wins approval for gene therapy to treat hemophilia A
          BioMarin wins approval for gene therapy to treat hemophilia A

          AdobeTheFoodandDrugAdministrationonThursdayapprovedagenetherapytotreatpeoplewithhemophiliaA,aninheri

          read more

          The high cost of giving birth even with insurance

          AdobeTheburdenofhighhealthcarecostsandmedicaldebtintheU.S.isnosecret.Medicaldebtaffectsoneinfiveadul